Casana Stock
Heart Health Intelligence creates grade heart health monitoring while bypassing the need for patient adherence.
Sign up today and learn more about Casana Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Casana Stock
Casana is unlocking a new category in healthcare technologies that enable effortless, integrated and consistent in-home heart health monitoring. Casana’s first product, The Heart Seat™ is an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output. Casana’s mission is to assist medical teams in their care management of patients with chronic conditions beyond the four walls of the hospital, starting with the 6M+ people in the US living with Heart Failure.
Funding History
| October 2019 | $50K |
|---|---|
| October 2019 | $25K |
| April 2020 | $2.2M |
| August 2020 | $30K |
| February 2021 | $14.0M |
| January 2022 | $30.0M |
Management
Chairman
Jeffrey Leiden
Founder & Chief Scientific Officer
Nicholas Conn
Head Of R&D
David Borkholder
Chief Commercial Officer
Olivia Lew
Chief Operating Officer
Ken Rosenfeld
Board Member
Paul Sagan
Press
mpo-mag - Aug, 23 2023
Shikha Anand Joins Casana as Chief Medical Officerglobenewswire - Feb, 23 2023
Casana Appoints New CTO To Accelerate Technological Innovation in Remote Patient Monitoringmobihealthnews - Apr, 3 2020
Heart Health Intelligence scores $2.2M for its heart data collecting toilet seatEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
